Comparison between GNH India Pharmaceuticals IPO and Kiaasa Retail IPO.
GNH India Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Kiaasa Retail IPO is a SME Bookbuilding proposed to list at BSE SME.
| GNH India Pharmaceuticals IPO | Kiaasa Retail IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Gretex Corporate Services Ltd. | Expert Global Consultants Pvt.Ltd. |
| Registrar | Purva Sharegistry (India) Pvt.Ltd. | Purva Sharegistry (India) Pvt.Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | Prabhat Financial Services Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of GNH India Pharmaceuticals IPO is up to ₹0.00 Cr whereas the issue size of the Kiaasa Retail IPO is up to ₹66.24 Cr. The final issue price of GNH India Pharmaceuticals IPO is and of Kiaasa Retail IPO is ₹127.00 per share.
| GNH India Pharmaceuticals IPO | Kiaasa Retail IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹121.00 per share | |
| Issue Price (Upper) | ₹127.00 per share | |
| Issue Price (Final) | ₹127.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | |
| Fresh Issue Size | 37,00,000 shares | 52,16,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹66.24 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 52,16,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹66.24 Cr |
GNH India Pharmaceuticals IPO opens on , while Kiaasa Retail IPO opens on Feb 23, 2026. The closing date of GNH India Pharmaceuticals IPO and Kiaasa Retail IPO is , and Feb 25, 2026, respectively.
| GNH India Pharmaceuticals IPO | Kiaasa Retail IPO | |
|---|---|---|
| Anchor Bid Date | Feb 20, 2026 | |
| Issue Open | Feb 23, 2026 | |
| Issue Close | Feb 25, 2026 | |
| Basis Of Allotment (Tentative) | Feb 26, 2026 | |
| Initiation of Refunds (Tentative) | Feb 27, 2026 | |
| Credit of Share (Tentative) | Feb 27, 2026 | |
| Listing date (Tentative) | Mar 02, 2026 | |
| Anchor Lockin End date 1 | Mar 28, 2026 | |
| Anchor Lockin End date 2 | May 27, 2026 |
GNH India Pharmaceuticals IPO P/E ratio is , as compared to Kiaasa Retail IPO P/E ratio of 19.31.
| GNH India Pharmaceuticals IPO | Kiaasa Retail IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 71.84 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 50.22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 19.31 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹231.51 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 22.99% | 42.36% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.49% | 20.34% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.70 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.58 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 16.81% | 20.60% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the GNH India Pharmaceuticals IPO Retail Individual Investors (RII) are offered while in Kiaasa Retail IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in GNH India Pharmaceuticals IPO and 52,000 shares in Kiaasa Retail IPO.
| GNH India Pharmaceuticals IPO | Kiaasa Retail IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 2,75,000 shares | |
| QIB | 52,000 shares | |
| NII | 20,87,000 shares | |
| RII | 30,76,000 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 52,15,000 shares |
GNH India Pharmaceuticals IPO subscribed in total, whereas Kiaasa Retail IPO subscribed 2.05x.
| GNH India Pharmaceuticals IPO | Kiaasa Retail IPO | |
|---|---|---|
| QIB (times) | 14.98x | |
| NII (times) | 1.16x | |
| Big NII (times) | 1.29x | |
| Small NII (times) | 0.90x | |
| RII (times) | 2.43x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.05x |
